High impact
Medical policy updates
Blue Cross Blue Shield of Rhode Island·Effective Mar 1, 2025
HCPCS S3866 is officially defined as "Genetic analysis for a specific gene mutation for hypertrophic cardiomyopathy (hcm) in an individual with a known hcm mutation in the family." HCPCS S3866 is referenced in 1 tracked payer policy change from Blue Cross Blue Shield of Rhode Island. For billers and coders, staying current on payer-specific coverage criteria, reimbursement rules, and prior-authorization requirements for HCPCS S3866 is critical to clean claim submission. Each entry below links to the full policy analysis with effective dates and action steps.
Related
Get alerts for changes like this
Save a search and receive a daily digest whenever a new policy change matches your filters.